Novocure
Sharon Perez is a highly experienced professional in the field of medical safety and pharmacovigilance, currently serving as Vice President of Global Medical Safety at Novocure since November 2012, following a tenure as Director in the same department. Prior experience includes Associate Director of Global Drug Safety Medicine at EMD Serono and various roles at Genzyme, including Senior Associate and Staff Scientist in Pharmacovigilance and Pharmacology & Toxicology. Sharon began the career as a Postdoctoral Fellow in Neurology at Harvard Medical School. Educational qualifications include a Ph.D. in Cell/Cellular and Molecular Biology from the University of Maryland Baltimore and a BS in Biotechnology from the Rochester Institute of Technology.
This person is not in any offices
Novocure
3 followers
Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. Novocure’s commercialized products are approved in certain countries for the treatment of adult patients with glioblastoma and in the U.S. for the treatment of adult patients with malignant pleural mesothelioma.